Pharmafile Logo

Solving your biggest patient recruitment and retention challenges

- PMLiVE

Clinical trial patient recruitment and retention remains one of the key challenges to successfully bringing a new therapeutic to market. An estimated 85% of clinical trials face delays due to enrollment issues [1,2], and poor recruitment is a common reason for discontinuation [3]. Of those successfully enrolled, around 30% are likely to drop out [4], which increases costs for sponsors and threatens the viability of the trial itself.

Directly supporting patients from prescreening to study endpoint can help minimize delays and safeguard against early termination, but this can be difficult for hard-pressed sites. Join us as we discuss the most common patient support challenges – as described to us by YOU – and how our new Navigator can solve them by giving patients a more personalized clinical trial experience and consistent contact, alleviating the burden on sites, and ensuring a sponsor’s study runs efficiently to help accelerate patient access to life-changing treatments.

We will share our insight into why the ‘human touch’ can elevate your in-study patient engagement to the next level and how this permeates through our Navigator service to benefit patients, sites and sponsors. You will also hear from a sponsor that has benefitted from our expertise: the difficulties they faced, the solutions we implemented and the difference we made. And we will share feedback from clinical trial participants about what they think of our support.

This content was provided by Innovative Trials

Company Details

 Latest Content from  Innovative Trials 

Kate Shaw reflects on Innovative Trials’ first US office openings

On Thanksgiving, Kate Shaw, Founder and CEO of Innovative Trials, reflects on the company first US office opening

Innovative Trials on the latest ABPI report

Kate Shaw, Innovative Trials Founder & CEO, commented on the latest ABPI report

Innovative Trials featuring in a Clinical Trials Arena article

Leanne Keem, Head of Operations and Client Relationship at Innovative Trials, featured in a recent article.

Overcoming Patient Recruitment Challenges in Rare Disease Trials

Rare diseases are thought to affect up to 446 million people worldwide. With more than 7,000 rare diseases, most of which are genetic, it’s vital all patients can access new...

FREE Live Webinar – Overcoming Patient Recruitment Challenges in Rare Disease Trials

Innovative Trials and Pfizer invite you to attend the live webinar

Innovative Trials opens first US office

We are incredibly excited to announce the opening of our very first US office! This is an incredible milestone towards our mission to accelerate clinical development. Read the full press...

Accelerating patient recruitment post-COVID-19

COVID-19 has hugely affected clinical trials and patient recruitment, with the entire industry on hold for some time causing backlogs and delays most of the studies.

Innovative Trials opens first US office

The leading global patient recruitment organisation has opened its first international office in the Raleigh, North Carolina

Windrush Day

Innnovative Trials' Equality & Diversity committee raises awareness around Windrush Day and the Windrush generation

Celebrating World Blood Donor Day

Each 14th June World Blood Donor day is celebrated around the world to spread awareness around the importance of giving blood.